SUN PHARMACEUTICAL INDUSTRIES LTD.
Quaterly Results
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Audited / UnAudited | UnAudited | UnAudited | UnAudited | Audited |
Net Sales | 123807 | 121924.1 | 119408.4 | 109306.7 |
Total Expenditure | 90284.3 | 90130.3 | 86111.1 | 81285.4 |
PBIDT (Excl OI) | 33522.7 | 31793.8 | 33297.3 | 28021.3 |
Other Income | 3747.6 | 2936.1 | 2064.8 | 3732.8 |
Operating Profit | 37270.3 | 34729.9 | 35362.1 | 31754.1 |
Interest | 347.3 | 492.9 | 808.8 | 927.4 |
Exceptional Items | -698.1 | NA | -3228.7 | -1714.5 |
PBDT | 36224.9 | 34237 | 31324.6 | 29112.2 |
Depreciation | 6221.4 | 6328.2 | 6513.2 | 6715.3 |
Profit Before Tax | 30003.5 | 27908.8 | 24811.4 | 22396.9 |
Tax | 4323.2 | 3901 | 4681 | 2229.1 |
Provisions and contingencies | NA | NA | NA | NA |
Profit After Tax | 25680.3 | 24007.8 | 20130.4 | 20167.8 |
Extraordinary Items | NA | NA | NA | NA |
Prior Period Expenses | NA | NA | NA | NA |
Other Adjustments | NA | NA | NA | NA |
Net Profit | 25680.3 | 24007.8 | 20130.4 | 20167.8 |
Minority Interest | -367.9 | -95.9 | 168.9 | 15.7 |
Shares of Associates | -74.9 | -156.8 | -73.9 | -338.81 |
Other related items | ||||
Misc. Expenses Written off | NA | NA | NA | NA |
Consolidated Net Profit | 25237.5 | 23755.1 | 20225.4 | 19844.7 |
Equity Capital | 2399.3 | 2399.3 | 2399.3 | 2399.3 |
Face Value (IN RS) | 1 | 1 | 1 | 1 |
Reserves | NA | NA | NA | NA |
Calculated EPS | 10.51 | 9.90 | 8.42 | 8.27 |
Calculated EPS (Annualised) | 42.07 | 39.60 | 33.71 | 33.08 |
No of Public Share Holdings | 1092200435 | 1092200435 | 1092200435 | 1092200435 |
% of Public Share Holdings | 45.52 | 45.52 | 45.52 | 45.51 |
| NA | NA | NA | NA |
PBIDTM% (Excl OI) | 27.07 | 26.07 | 27.88 | 25.63 |
PBIDTM% | 30.10 | 28.48 | 29.61 | 29.05 |
PBDTM% | 29.25 | 28.08 | 26.23 | 26.63 |
PBTM% | 24.23 | 22.89 | 20.77 | 20.48 |
PATM% | 20.74 | 19.69 | 16.85 | 18.45 |
"; | Notes | Notes | Notes | Notes |